529 results on '"Kaufmann, Daniel E."'
Search Results
2. Circulating proteins to predict COVID-19 severity
3. Enhanced detection of antigen-specific T cells by a multiplexed AIM assay
4. Spontaneous HIV expression during suppressive ART is associated with the magnitude and function of HIV-specific CD4+ and CD8+ T cells
5. Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120
6. A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile
7. An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells
8. A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
9. Humoral immune responses against SARS-CoV-2 Spike variants after mRNA vaccination in solid organ transplant recipients
10. Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals
11. The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals
12. Single-Cell Multiparametric Analysis of Rare HIV-Infected Cells Identified by Duplexed RNAflow-FISH
13. Impact of cobas PCR Media freezing on SARS-CoV-2 viral RNA integrity and whole genome sequencing analyses
14. Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis
15. Combined single-cell transcriptional, translational, and genomic profiling reveals HIV-1 reservoir diversity
16. Translocated microbiome composition determines immunological outcome in treated HIV infection
17. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
18. HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes.
19. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity
20. Excess BAFF May Impact HIV-1-Specific Antibodies and May Promote Polyclonal Responses Including Those from First-Line Marginal Zone B-Cell Populations
21. Gaining Biological Insights through Supervised Data Visualization
22. Dynamic gene expression analysis reveals distinct severity phases of immune and cellular dysregulation in COVID-19
23. Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity
24. HIV and SIV, CD4 T-Cell Responses to
25. Impact of Prolonged SARS-CoV-2 Dosing Interval in Hemodialysis Patients
26. Targeting Mitochondria to Revive Dysfunctional Regulatory T Cells
27. Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy–Treated Individuals With Undetectable Viremia.
28. Humoral Responses Elicited after a Fifth Dose of SARS-CoV-2 mRNA Bivalent Vaccine
29. Plasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremia
30. Failed immune responses across multiple pathologies share pan-tumor and circulating lymphocytic targets
31. Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease
32. Immunophenotyping of peripheral blood mononuclear cells in tuberous sclerosis complex
33. Daily variations of gut microbial translocation markers in ART-treated HIV-infected people
34. Plasma SARS‐CoV‐2 RNA elimination and RAGE kinetics distinguish COVID‐19 severity.
35. Tools for Visualizing HIV in Cure Research
36. Humoral Responses against BQ.1.1 Elicited after Breakthrough Infection and SARS-CoV-2 mRNA Vaccination
37. Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
38. On-demand, hospital-based, severe acute respiratory coronavirus virus 2 (SARS-CoV-2) genomic epidemiology to support nosocomial outbreak investigations: A prospective molecular epidemiology study
39. Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique
40. CXCL13 is a plasma biomarker of germinal center activity
41. Excess BAFF Alters NR4As Expression Levels and Breg Function of Human Precursor-like Marginal Zone B-Cells in the Context of HIV-1 Infection
42. Innate Immunity and SARS-CoV-2 Vaccine Response in Hemodialysis Patients
43. Intra-host viral populations of SARS-CoV-2 in immunosuppressed patients with hematologic cancers
44. Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function
45. CD4 mimetics sensitize HIV-1-infected cells to ADCC
46. A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile
47. Detecting Sources of Immune Activation and Viral Rebound in HIV Infection
48. A long interval between priming and boosting SARS-CoV-2 mRNA vaccine doses enhances B cell responses with limited impact on T cell immunity
49. SARS-CoV-2 Omicron subvariants Spike recognition and neutralization elicited after the third dose of mRNA vaccine
50. Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.